IJAPS logo International Journal of Applied Pharmaceutical SciencesISSN 2394-7446 (Online) · Peer-reviewed · Open access
📝 For Authors

Submission of Manuscript

Guidelines for preparing and submitting your manuscript to IJAPS.

Submit Your Manuscript Online

IJAPS accepts manuscripts through its online submission system. Log in or register as an author, then follow the steps to upload your anonymised manuscript, title page and other files. You can track the status of your manuscript and peer review from your author dashboard.

If you have difficulty using the online system, email your manuscript to ijapseditor@gmail.com. The editorial office acknowledges every submission and sends a technical-check decision within 7 days.

Submission Workflow

  1. Register / log in to the online submission system.
  2. Submit the anonymised manuscript, separate title page, cover letter and signed declaration form. You receive an acknowledgement by email.
  3. Technical check (within 7 days): scope, formatting, completeness and similarity check.
  4. Peer review: double-blind review by at least two independent experts.
  5. Decision: accept, minor revision, major revision or reject – first decision targeted within 6 weeks.
  6. Revision: revised manuscript with a point-by-point response, within 2 weeks (minor) or 4 weeks (major).
  7. Acceptance and APC: the article processing charge is payable only after acceptance (waivers available).
  8. Production: copy-editing, typesetting and author proof check.
  9. Publication: the article is published open access in the next issue, with a DOI.

See also: Copyright & Licensing · Article Withdrawal · Privacy Statement · Reviewer Guidelines

Author Guidelines

Please prepare your manuscript according to these guidelines before submitting it to the International Journal of Applied Pharmaceutical Sciences (IJAPS). Manuscripts that do not follow them may be returned without review.

General requirements
  • Manuscripts must be original, written in clear English, and not published or under consideration elsewhere.
  • Use Microsoft Word (.doc/.docx), Times New Roman 12 pt, 1.5 line spacing, with page and line numbers.
  • Use SI units and generic (INN) drug names.
Files to submit
  • Title page (separate file): title, full names of all authors (without honorifics such as Dr., Mr. or Mrs.), affiliations with department, institution, city and country, ORCID iDs if available, and the corresponding author’s name, postal address, phone and email.
  • Anonymised manuscript: no author names, affiliations or acknowledgements, and no self-identifying references, for double-blind review.
  • Cover letter confirming originality, that the work is not under consideration elsewhere, and that all authors approve the submission.
  • Author Declaration & Licence Form, signed by the corresponding author on behalf of all authors (see Downloads).
Manuscript structure
  • Title: concise and informative.
  • Abstract: up to 250 words; structured (Objective, Methods, Results, Conclusion) for research articles.
  • Keywords: 4–6.
  • Main text: Introduction, Materials and Methods, Results, Discussion, Conclusion for research articles; logical headings for reviews; Introduction, Case Presentation, Discussion, Conclusion for case reports.
  • Declarations: ethics approval and consent, conflicts of interest, funding, author contributions, and any use of generative AI tools.
  • References: Vancouver style, numbered in order of citation in square brackets [1]. Give all authors up to six, then “et al.”, and include DOIs where available.
  • Tables and figures: numbered, cited in the text, each with a title; figures at a minimum of 300 dpi.
Ethics
  • Human studies need Institutional Ethics Committee approval and informed consent; case reports need written patient consent.
  • Animal studies need Institutional Animal Ethics Committee (IAEC) approval under CCSEA guidelines. State approval numbers in the Methods.
  • All manuscripts are screened for similarity. See the plagiarism and publication ethics policy.

Article Types

  • Research Article – original experimental or clinical investigations.
  • Review Article – narrative or systematic reviews, including meta-analyses.
  • Short Communication – brief reports of significant preliminary findings.
  • Case Report – clinical observations of diagnostic, therapeutic or adverse-event interest.

Fees & Licence

No submission fee. An article processing charge is payable only after acceptance: ₹5,000 for Indian authors (inclusive of all taxes) and US$150 for international authors. Waivers are available for authors from low-income countries, student first authors (50%) and authors without funding. See Article Processing Charges.

Authors retain copyright. Articles are published open access under the Creative Commons Attribution 4.0 (CC BY 4.0) licence.

Submission Checklist

  • Title page with all author details, as a separate file
  • Anonymised manuscript (Word), abstract up to 250 words and 4–6 keywords
  • References in Vancouver style
  • Ethics approval and consent statements, where applicable
  • Conflict of interest, funding and AI-use declarations
  • Cover letter
  • Signed Author Declaration & Licence Form

Downloads & Forms

Download the author instructions and the declaration form required with every submission.

Download Instructions (PDF)

Download Declaration Form (PDF)